C-Terminal Alpha-1 Antitrypsin Peptide: A New Sepsis Biomarker with Immunomodulatory Function
Systemic inflammatory response syndrome (SIRS) is a life threatening condition and the leading cause of death in intensive care units. Although single aspects of pathophysiology have been described in detail, numerous unknown mediators contribute to the progression of this complex disease. The aim o...
Main Authors: | Nancy Blaurock, Diana Schmerler, Kerstin Hünniger, Oliver Kurzai, Katrin Ludewig, Michael Baier, Frank Martin Brunkhorst, Diana Imhof, Michael Kiehntopf |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2016/6129437 |
Similar Items
-
Targeted metabolomics for discrimination of systemic inflammatory disorders in critically ill patients
by: Diana Schmerler, et al.
Published: (2012-07-01) -
CAAP48, a New Sepsis Biomarker, Induces Hepatic Dysfunction in an in vitro Liver-on-Chip Model
by: Nancy Blaurock-Möller, et al.
Published: (2019-02-01) -
Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
by: Irina Petrache, et al.
Published: (2009-05-01) -
Plasma levels of α1-antitrypsin-derived C-terminal peptides in PiMM and PiZZ COPD patients
by: Friedemann R. Börner, et al.
Published: (2023-12-01) -
Alpha-1-antitrypsin as novel substrate for S. aureus’ Spl proteases – implications for virulence
by: Franziska Scherr, et al.
Published: (2024-11-01)